A study that included 230 patients with IgAN who were followed up for an average of 22 months found that an elevated serum Gd-IgA1 level was an independent risk factor for progression of chronic kidney disease (CKD, namely, a decrease in eGFR of > 25% or a decrease in eGFR classification) [30]. This evidence concerns the gene IGHA1 and chronic kidney disease.